Creating a free account will enable you to subscribe to our daily and weekly email newsletters, as well as customize your reading experience to show only the categories most relevant to you.
Signing up only take a few minutes, so why not give it a try and see what you've been missing out on.
The Annals of the American Thoracic Society has released a comprehensive supplement on the 56th annual Thomas L. Petty Aspen Lung Conference entitled "The Lung Microbiome: A New Frontier in Pulmonary Medicine."
More than 170 microbiologists, basic respiratory scientists, and pulmonary clinicians traveled from nine countries to convene at the three-day conference, which took place in June 2013 in Aspen, CO. Research from 12 state-of-the-art speakers, 24 oral research presentations, and 20 posters from pioneers in the emerging field are included in the supplement, as well as an introduction from conference chairs Richard J. Martin, MD, Sonia Flores, PhD, and Monica Kraft, MD, and a conference summary from James Kiley, PhD.
"The lungs of healthy humans have traditionally been considered to be sterile when examined by culture-based techniques," James Beck, MD, chief of medicine at the VA Eastern Colorado Health Care System in Denver, notes in his presentation. "However, molecular identification techniques are now being used to explore the lung microbiome in ways that mirror study of other body sites and organ systems. This emerging and exciting field of investigation is leading to new ways of thinking about the lung and about lung disease."
In the conference summary, Dr. Kiley, the director of the Division of Lung Diseases at National Heart, Lung, and Blood Institute, notes: "This meeting highlighted early scientific progress in understanding the lung microbiota in healthy and diseased subjects, addressed current challenges and opportunities, and discussed trends and future directions for functional studies to unravel the mechanism of disease and a more defined role of microorganisms in health.
"Part of the new frontier is that microbes were originally considered the 'enemy,' and the approach was to eradicate a bug and cure the disease. We now recognize this paradigm has evolved from microbes being enemies to being partners, and a new challenge is to understand the delicate balance and symbiosis of those communities in defining the role of the microbiome(s) in health and disease."
Article adapted by Medical News Today from original press release. Click 'references' tab above for source.
Visit our Respiratory / Asthma category page for the latest news on this subject.
Please use one of the following formats to cite this article in your essay, paper or report:
American Thoracic Society. "The lung microbiome: A new frontier in pulmonary medicine." Medical News Today. MediLexicon, Intl., 28 Jan. 2014. Web.
9 Mar. 2014. <http://www.medicalnewstoday.com/releases/271703>
American Thoracic Society. (2014, January 28). "The lung microbiome: A new frontier in pulmonary medicine." Medical News Today. Retrieved from
Please note: If no author information is provided, the source is cited instead.
If you write about specific medications, operations, or procedures please do not name healthcare professionals by name.
For any corrections of factual information, or to contact our editorial team, please use our feedback form. Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
This page was printed from: http://www.medicalnewstoday.com/releases/271703.php
Visit www.medicalnewstoday.com for medical news and health news headlines posted throughout the day, every day.
© 2004-2014 All rights reserved. MNT (logo) is the registered trade mark of MediLexicon International Limited.